8 Shenoy M,Baron S,Wu B,et al.IFN-α treatment suppresses the development of experimental autoimmune myasthenia gravis.J Immunol,1995,154(12):6203
9 Rein J, McIntosh KR,Drachman D.Acetylcholine receptor pre-sentation by B cells using heterobifunctional antibody conjugates.Ann NY Acad Sci,1993,(681):325
10 Souroujon MC, Carmon S, Fuchs S. Regulation of experimental autoimmune myasthynia gravis by synthetic peptides of the acetylcho-line receptor. Ann NY acad Sci, 1993, (681):332
11 Link J,Fredrikson S,Soderstrom M,et al.Organ-specific autoan-tigens induce transforming growth factor-β mRNA expression in mononuclear cells in multipl sclerosis and myasthenia gravis.Ann Neurol,1994,35(2):197
12 Wu B,Shenoy M,Goluszko E,et al.TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis.J Immunol,1995,154(7):3603
13 Kaul R,Shenoy M,Goluszko E,et al.Major histocompatibility complwex class II gene disruption prevents experimental autoimmune myasthenia gravis.J Immunol,1994,152(6):3152
